Published trade mark details for 2276146
This information was published on 2022-06-10T14:21:48 for IP Right Filed Published.
| Field | Value |
| (210) | 2276146 |
| (220) |
10 Jun 2022
|
| (300) |
US, 17 Feb 2022, 97272575
|
| (511) (510) |
Class 5
Oligonucleotide-conjugate based therapies; oligonucleotide-antibody conjugate based therapies; oligonucleotide-antibody fragment conjugate based therapies; synthetic oligonucleotides; antibodies; monoclonal antibodies for medical use; immunological products; oligonucleotide compounds for use in the delivery of RNA therapy; drug delivery agents comprising oligonucleotide compounds that facilitate the delivery of pharmaceutical based therapies |
| (540) |
|
| (550) | Figurative |
| (730) |
Avidity Biosciences, Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.